Phio Pharmaceuticals
PHIO
#10948
Rank
โ‚ฌ8.35 M
Marketcap
0,70ย โ‚ฌ
Share price
-5.03%
Change (1 day)
-38.39%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -โ‚ฌ11.15 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ7.9 Million a decrease over its 2024 earnings that were of -โ‚ฌ6.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ11.15 Million41.19%
2025 -โ‚ฌ7.9 Million21.65%
2024 -โ‚ฌ6.49 Million-33.96%
2023 -โ‚ฌ9.83 Million-5.7%
2022 -โ‚ฌ10.42 Million-13.6%
2021 -โ‚ฌ12.06 Million51.09%
2020 -โ‚ฌ7.98 Million-1.28%
2019 -โ‚ฌ8.09 Million21.03%
2018 -โ‚ฌ6.68 Million-53.1%
2017 -โ‚ฌ14.24 Million74.49%
2016 -โ‚ฌ8.16 Million-12.02%
2015 -โ‚ฌ9.28 Million16.17%
2014 -โ‚ฌ7.99 Million-57.95%
2013 -โ‚ฌ18.99 Million62.45%
2012 -โ‚ฌ11.69 Million0.87%
2011 -โ‚ฌ11.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.15 Billion 1,133.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ16.48 Million 40.70%๐Ÿ‡บ๐Ÿ‡ธ USA